Warnex has finalised an agreement with Foss UK to distribute and market the Warnex rapid pathogen detection system in the United Kingdom and Ireland
"We are pleased to expand our relationship with Foss to include distribution in the UK and Ireland," said Mark Busgang, president and CEO.
"The 11 systems sold since March 2004 speaks to Foss Italia's success with the sale of the Warnex system in Italy and we are looking forward to extending this progress in the UK and Ireland." Foss UK is a wholly owned subsidiary of Foss A/S based in Denmark.
Founded in 1956, Foss is a provider of analytical solutions for the food, agricultural, chemical and pharmaceutical industries.
It has offices in 21 countries and more than 1100 employees.
Based in Warrington, Foss UK employs 42 people.
"The Warnex rapid pathogen detection system has provided clear and consistent benefits to Foss Italia clients".
"This palpable success has reinforced our belief in the value of this Warnex product", said Chris Ravenscroft, managing director of Foss UK.
"As such, we hope to replicate this success throughout our customer network in the United Kingdom and Ireland." Foss UK will replace Warnex's previous distributor for the UK, Don Whitley Scientific.
The Warnex rapid pathogen detection system uses cutting-edge DNA-based technology to rapidly and accurately determine the presence of pathogens in a sample.
The system allows for the simultaneous detection of multiple pathogens and processing of samples within three to 48 hours, a significant improvement over traditional microbiology tests that currently require five to seven days.
